Preclinical News and Research

RSS
NeoRx Corporation acquires worldwide rights to platinum-based anti-cancer agent

NeoRx Corporation acquires worldwide rights to platinum-based anti-cancer agent

Oxford Biomedica to win Department of Health gene funding

Oxford Biomedica to win Department of Health gene funding

GenVec malaria vaccine initiative and the U.S. Naval Medical Research Center has announced partnership for malaria vaccine

GenVec malaria vaccine initiative and the U.S. Naval Medical Research Center has announced partnership for malaria vaccine

Discovery of gender difference in cartilage cells may help spinal disc repair

Discovery of gender difference in cartilage cells may help spinal disc repair

Genencor Sells Its Therapeutic Vaccine Program to Innogenetics

Genencor Sells Its Therapeutic Vaccine Program to Innogenetics

Data on pre-clinical activity of satraplatin in prostate cancer to be released

Data on pre-clinical activity of satraplatin in prostate cancer to be released

Novel vaccine technology to suppress the growth of certain tumors

Novel vaccine technology to suppress the growth of certain tumors

Immunomodulator induces long-term anti-tumor activity

Immunomodulator induces long-term anti-tumor activity

New Research Information on Tumor Necrosis Therapy

New Research Information on Tumor Necrosis Therapy

Partnership to improve TB vaccine, Bacillus Calmette-Guérin (BCG)

Partnership to improve TB vaccine, Bacillus Calmette-Guérin (BCG)

Oregon Stem Cell Center Hunt for Human Disease Therapies

Oregon Stem Cell Center Hunt for Human Disease Therapies

AMT Obtains Orphan Drug Designation for Its LPL Gene Therapy Product

AMT Obtains Orphan Drug Designation for Its LPL Gene Therapy Product

New treatment for heart attacks

New treatment for heart attacks

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.